REPORT ID 13724

Global Anthrax Vaccines Market Research Report 2017

Publish Date
22-Nov-17
Pages
129
Format
Electronic (PDF)

In this report, the global Anthrax Vaccines market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Anthrax Vaccines in these regions, from 2012 to 2022 (forecast), covering
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
Global Anthrax Vaccines market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
    Agrovet
    Bayer Sanidad Animal
    Biog?nesis-Bago S.A.
    Botswana Vaccine Institute
    CAVAC
    Central Veterinary Control and Research Institute
    Centro Diagn?stico Veterinario
    Ceva Sante Animale
    Colorado Serum Company
    Empresa Colombiana de Productos Veterinarios S.A. (Vecol)
    Indian Immunologicals Limited
    Institute for Biological Products
    Institute of Animal Health and Veterinary Biologicals
    Institute of Veterinary Preventive Medicine
    Instituto Rosenbusch S.A.
    Institutul Pasteur
    Intervac (PVT) Ltd.
    Jordan Bio-Industries Center (JOVAC)
    KAKETSUKEN (Chemo-Sero-Therapeutic Research Institute)
    Laboratorio Prondil S.A.
    Laboratorios Laverlam S.A.
    Merial Argentina
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Cell Free PA Vaccines: Anthrax Vaccine Adsorbed (AVA) , Anthrax Vaccine Precipitated (AVP)
    Live Vaccines
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
    Human
    Animals

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Anthrax Vaccines Market Research Report 2017
1 Anthrax Vaccines Market Overview
    1.1 Product Overview and Scope of Anthrax Vaccines
    1.2 Anthrax Vaccines Segment by Type (Product Category)
        1.2.1 Global Anthrax Vaccines Production and CAGR (%) Comparison by Type (Product Category)(2012-2022)
        1.2.2 Global Anthrax Vaccines Production Market Share by Type (Product Category) in 2016
        1.2.3 Cell Free PA Vaccines: Anthrax Vaccine Adsorbed (AVA) , Anthrax Vaccine Precipitated (AVP)
        1.2.4 Live Vaccines
    1.3 Global Anthrax Vaccines Segment by Application
        1.3.1 Anthrax Vaccines Consumption (Sales) Comparison by Application (2012-2022)
        1.3.2 Human
        1.3.3 Animals
    1.4 Global Anthrax Vaccines Market by Region (2012-2022)
        1.4.1 Global Anthrax Vaccines Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
        1.4.2 North America Status and Prospect (2012-2022)
        1.4.3 Europe Status and Prospect (2012-2022)
        1.4.4 China Status and Prospect (2012-2022)
        1.4.5 Japan Status and Prospect (2012-2022)
        1.4.6 Southeast Asia Status and Prospect (2012-2022)
        1.4.7 India Status and Prospect (2012-2022)
    1.5 Global Market Size (Value) of Anthrax Vaccines (2012-2022)
        1.5.1 Global Anthrax Vaccines Revenue Status and Outlook (2012-2022)
        1.5.2 Global Anthrax Vaccines Capacity, Production Status and Outlook (2012-2022)

2 Global Anthrax Vaccines Market Competition by Manufacturers
    2.1 Global Anthrax Vaccines Capacity, Production and Share by Manufacturers (2012-2017)
        2.1.1 Global Anthrax Vaccines Capacity and Share by Manufacturers (2012-2017)
        2.1.2 Global Anthrax Vaccines Production and Share by Manufacturers (2012-2017)
    2.2 Global Anthrax Vaccines Revenue and Share by Manufacturers (2012-2017)
    2.3 Global Anthrax Vaccines Average Price by Manufacturers (2012-2017)
    2.4 Manufacturers Anthrax Vaccines Manufacturing Base Distribution, Sales Area and Product Type
    2.5 Anthrax Vaccines Market Competitive Situation and Trends
        2.5.1 Anthrax Vaccines Market Concentration Rate
        2.5.2 Anthrax Vaccines Market Share of Top 3 and Top 5 Manufacturers
        2.5.3 Mergers & Acquisitions, Expansion

3 Global Anthrax Vaccines Capacity, Production, Revenue (Value) by Region (2012-2017)
    3.1 Global Anthrax Vaccines Capacity and Market Share by Region (2012-2017)
    3.2 Global Anthrax Vaccines Production and Market Share by Region (2012-2017)
    3.3 Global Anthrax Vaccines Revenue (Value) and Market Share by Region (2012-2017)
    3.4 Global Anthrax Vaccines Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.5 North America Anthrax Vaccines Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.6 Europe Anthrax Vaccines Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.7 China Anthrax Vaccines Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.8 Japan Anthrax Vaccines Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.9 Southeast Asia Anthrax Vaccines Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.10 India Anthrax Vaccines Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 Global Anthrax Vaccines Supply (Production), Consumption, Export, Import by Region (2012-2017)
    4.1 Global Anthrax Vaccines Consumption by Region (2012-2017)
    4.2 North America Anthrax Vaccines Production, Consumption, Export, Import (2012-2017)
    4.3 Europe Anthrax Vaccines Production, Consumption, Export, Import (2012-2017)
    4.4 China Anthrax Vaccines Production, Consumption, Export, Import (2012-2017)
    4.5 Japan Anthrax Vaccines Production, Consumption, Export, Import (2012-2017)
    4.6 Southeast Asia Anthrax Vaccines Production, Consumption, Export, Import (2012-2017)
    4.7 India Anthrax Vaccines Production, Consumption, Export, Import (2012-2017)

5 Global Anthrax Vaccines Production, Revenue (Value), Price Trend by Type
    5.1 Global Anthrax Vaccines Production and Market Share by Type (2012-2017)
    5.2 Global Anthrax Vaccines Revenue and Market Share by Type (2012-2017)
    5.3 Global Anthrax Vaccines Price by Type (2012-2017)
    5.4 Global Anthrax Vaccines Production Growth by Type (2012-2017)

6 Global Anthrax Vaccines Market Analysis by Application
    6.1 Global Anthrax Vaccines Consumption and Market Share by Application (2012-2017)
    6.2 Global Anthrax Vaccines Consumption Growth Rate by Application (2012-2017)
    6.3 Market Drivers and Opportunities
        6.3.1 Potential Applications
        6.3.2 Emerging Markets/Countries

7 Global Anthrax Vaccines Manufacturers Profiles/Analysis
    7.1 Agrovet
        7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.1.2 Anthrax Vaccines Product Category, Application and Specification
            7.1.2.1 Product A
            7.1.2.2 Product B
        7.1.3 Agrovet Anthrax Vaccines Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.1.4 Main Business/Business Overview
    7.2 Bayer Sanidad Animal
        7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.2.2 Anthrax Vaccines Product Category, Application and Specification
            7.2.2.1 Product A
            7.2.2.2 Product B
        7.2.3 Bayer Sanidad Animal Anthrax Vaccines Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.2.4 Main Business/Business Overview
    7.3 Biog?nesis-Bago S.A.
        7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.3.2 Anthrax Vaccines Product Category, Application and Specification
            7.3.2.1 Product A
            7.3.2.2 Product B
        7.3.3 Biog?nesis-Bago S.A. Anthrax Vaccines Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.3.4 Main Business/Business Overview
    7.4 Botswana Vaccine Institute
        7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.4.2 Anthrax Vaccines Product Category, Application and Specification
            7.4.2.1 Product A
            7.4.2.2 Product B
        7.4.3 Botswana Vaccine Institute Anthrax Vaccines Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.4.4 Main Business/Business Overview
    7.5 CAVAC
        7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.5.2 Anthrax Vaccines Product Category, Application and Specification
            7.5.2.1 Product A
            7.5.2.2 Product B
        7.5.3 CAVAC Anthrax Vaccines Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.5.4 Main Business/Business Overview
    7.6 Central Veterinary Control and Research Institute
        7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.6.2 Anthrax Vaccines Product Category, Application and Specification
            7.6.2.1 Product A
            7.6.2.2 Product B
        7.6.3 Central Veterinary Control and Research Institute Anthrax Vaccines Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.6.4 Main Business/Business Overview
    7.7 Centro Diagn?stico Veterinario
        7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.7.2 Anthrax Vaccines Product Category, Application and Specification
            7.7.2.1 Product A
            7.7.2.2 Product B
        7.7.3 Centro Diagn?stico Veterinario Anthrax Vaccines Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.7.4 Main Business/Business Overview
    7.8 Ceva Sante Animale
        7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.8.2 Anthrax Vaccines Product Category, Application and Specification
            7.8.2.1 Product A
            7.8.2.2 Product B
        7.8.3 Ceva Sante Animale Anthrax Vaccines Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.8.4 Main Business/Business Overview
    7.9 Colorado Serum Company
        7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.9.2 Anthrax Vaccines Product Category, Application and Specification
            7.9.2.1 Product A
            7.9.2.2 Product B
        7.9.3 Colorado Serum Company Anthrax Vaccines Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.9.4 Main Business/Business Overview
    7.10 Empresa Colombiana de Productos Veterinarios S.A. (Vecol)
        7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.10.2 Anthrax Vaccines Product Category, Application and Specification
            7.10.2.1 Product A
            7.10.2.2 Product B
        7.10.3 Empresa Colombiana de Productos Veterinarios S.A. (Vecol) Anthrax Vaccines Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.10.4 Main Business/Business Overview
    7.11 Indian Immunologicals Limited
    7.12 Institute for Biological Products
    7.13 Institute of Animal Health and Veterinary Biologicals
    7.14 Institute of Veterinary Preventive Medicine
    7.15 Instituto Rosenbusch S.A.
    7.16 Institutul Pasteur
    7.17 Intervac (PVT) Ltd.
    7.18 Jordan Bio-Industries Center (JOVAC)
    7.19 KAKETSUKEN (Chemo-Sero-Therapeutic Research Institute)
    7.20 Laboratorio Prondil S.A.
    7.21 Laboratorios Laverlam S.A.
    7.22 Merial Argentina

8 Anthrax Vaccines Manufacturing Cost Analysis
    8.1 Anthrax Vaccines Key Raw Materials Analysis
       8.1.1 Key Raw Materials
       8.1.2 Price Trend of Key Raw Materials
       8.1.3 Key Suppliers of Raw Materials
       8.1.4 Market Concentration Rate of Raw Materials
    8.2 Proportion of Manufacturing Cost Structure
       8.2.1 Raw Materials
       8.2.2 Labor Cost
       8.2.3 Manufacturing Expenses
    8.3 Manufacturing Process Analysis of Anthrax Vaccines

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
    9.1 Anthrax Vaccines Industrial Chain Analysis
    9.2 Upstream Raw Materials Sourcing
    9.3 Raw Materials Sources of Anthrax Vaccines Major Manufacturers in 2015
    9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
    10.1 Marketing Channel
        10.1.1 Direct Marketing
        10.1.2 Indirect Marketing
        10.1.3 Marketing Channel Development Trend
    10.2 Market Positioning
        10.2.1 Pricing Strategy
        10.2.2 Brand Strategy
        10.2.3 Target Client
    10.3 Distributors/Traders List

11 Market Effect Factors Analysis
    11.1 Technology Progress/Risk
        11.1.1 Substitutes Threat
        11.1.2 Technology Progress in Related Industry
    11.2 Consumer Needs/Customer Preference Change
    11.3 Economic/Political Environmental Change

12 Global Anthrax Vaccines Market Forecast (2017-2022)
    12.1 Global Anthrax Vaccines Capacity, Production, Revenue Forecast (2017-2022)
        12.1.1 Global Anthrax Vaccines Capacity, Production and Growth Rate Forecast (2017-2022)
        12.1.2 Global Anthrax Vaccines Revenue and Growth Rate Forecast (2017-2022)
        12.1.3 Global Anthrax Vaccines Price and Trend Forecast (2017-2022)
    12.2 Global Anthrax Vaccines Production, Consumption , Import and Export Forecast by Region (2017-2022)
        12.2.1 North America Anthrax Vaccines Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.2 Europe Anthrax Vaccines Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.3 China Anthrax Vaccines Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.4 Japan Anthrax Vaccines Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.5 Southeast Asia Anthrax Vaccines Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.6 India Anthrax Vaccines Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
    12.3 Global Anthrax Vaccines Production, Revenue and Price Forecast by Type (2017-2022)
    12.4 Global Anthrax Vaccines Consumption Forecast by Application (2017-2022)

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology/Research Approach
        14.1.1 Research Programs/Design
        14.1.2 Market Size Estimation
        14.1.3 Market Breakdown and Data Triangulation
    14.2 Data Source
        14.2.1 Secondary Sources
        14.2.2 Primary Sources
    14.3 Disclaimer